Dennis A. Ausiello - 21 Nov 2022 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Role
Director
Signature
By: /s/ Cynthia L Anderson, Attorney-in-Fact For: Dennis A. Ausiello
Issuer symbol
ALNY
Transactions as of
21 Nov 2022
Net transactions value
-$3,350,362
Form type
4
Filing time
23 Nov 2022, 15:05:26 UTC
Previous filing
24 Jun 2022
Next filing
27 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALNY Common Stock Options Exercise $789,750 +11,250 $70.20 11,250 21 Nov 2022 Direct F1
transaction ALNY Common Stock Options Exercise $809,888 +11,250 +100% $71.99 22,500 21 Nov 2022 Direct F1
transaction ALNY Common Stock Sale $4,950,000 -22,500 -100% $220.00 0 21 Nov 2022 Direct F1
holding ALNY Common Stock 3,500 21 Nov 2022 by Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALNY Stock Option (right to buy) Options Exercise $0 -11,250 -100% $0.000000* 0 21 Nov 2022 Common Stock 11,250 $70.20 Direct F1
transaction ALNY Stock Option (right to buy) Options Exercise $0 -11,250 -100% $0.000000* 0 21 Nov 2022 Common Stock 11,250 $71.99 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2022.
F2 The shares of ALNY common stock are held in a trust, of which the reporting person's spouse is the trustee.